Sign in

CIK 0001745999 · Large accelerated filer

Beam Therapeutics Inc.

Sign in to watch
Ticker
BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-327-8775
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Former names
Beam Therapeutics Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 8-K Event Other events
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 4 Open-market sale 10% owner sold 20,326 shares at an average $60.50 ($1,229,807)
  9. 8-K Event Other events
  10. 4 Open-market sale CEO sold 50,000 shares at an average $65.76 ($3,288,081)
  11. SC 13G Stake Amended Statement of Ownership
  12. 8-K Event Shareholder vote results
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations
  15. 4 Open-market sale CEO sold 50,000 shares at an average $37.98 ($1,898,899)
  16. DEFA14A Proxy Proxy Materials
  17. DEF 14A Proxy Proxy Statement
  18. 4 Open-market sale 10% owner sold 19,466 shares at an average $50.41 ($981,205)
  19. 4 Open-market sale President & CSO sold 1,859 shares at $59.11 ($109,885)
  20. 4 Open-market sale CEO sold 6,261 shares at $59.11 ($370,088)

Page 17 of 26 · 514 filings